Virtual care and health technology assessment considerations.


Journal

Healthcare management forum
ISSN: 0840-4704
Titre abrégé: Healthc Manage Forum
Pays: United States
ID NLM: 8805307

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 18 3 2022
medline: 29 4 2022
entrez: 17 3 2022
Statut: ppublish

Résumé

The COVID-19 pandemic resulted in a rapid adoption of virtual care. Virtual care existed before the pandemic for specific conditions and circumstances. Health Technology Assessment (HTA) of virtual care evaluated clinical and cost-effectiveness to inform decisions about the optimal use prior to the pandemic but the necessary implementation of virtual care during the pandemic meant HTA was not feasible prior to adoption. The questions for HTA no longer focused on clinical or cost-effectiveness and focused on implementation considerations. Health technology assessment post-adoption of virtual care included questions such as the appropriate medical conditions for virtual care, training, billing, patient and clinician perspectives and experiences, and equity of access. Moving forward, it is important for HTA organizations to identify new and emerging virtual care technologies, explore early and other types of evidence, assess the potential impact on the healthcare system, and explore the operational considerations.

Identifiants

pubmed: 35296161
doi: 10.1177/08404704211061954
doi:

Types de publication

Journal Article

Langues

eng

Pagination

127-129

Auteurs

Brit Cooper-Jones (B)

RinggoldID:6319Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada.

Jeff Mason (J)

RinggoldID:6319Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada.

Chris Kamel (C)

RinggoldID:6319Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada.

Nicole Mittmann (N)

RinggoldID:6319Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada.

Lesley Dunfield (L)

RinggoldID:6319Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH